CC
LAB icon

Curian Capital’s Standard BioTools LAB Stock Holding History

Curian Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-21,452
Closed -$174K – 518
2015
Q3 		$174K Sell
21,452
-8,626
-29% -$136K ﹤0.01% 561
2015
Q2 		$728K Buy
30,078
+8,380
+39% +$264K 0.01% 525
2015
Q1 		$913K Buy
21,698
+177
+0.8% +$7K 0.02% 477
2014
Q4 		$726K Buy
21,521
+7,647
+55% +$217K 0.01% 516
2014
Q3 		$340K Buy
+13,874
New +$390K 0.01% 571

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Curian Capital's LAB Position: Q4 2015 in Review

Curian Capital sold out of Standard BioTools (LAB) in Q4 2015, closing a stake of 21,452 shares — an estimated $174K sold.

Curian Capital first reported a position in LAB in Q3 2014 and held it in 5 quarters. The position peaked at $913K in Q1 2015. 106 funds tracked by Wall St. Rank hold LAB as of Q4 2015.

  • Curian Capital reported no remaining Standard BioTools position as of Q4 2015 after selling out during the quarter.
  • Curian Capital sold 21,452 Standard BioTools shares in Q4 2015, an estimated $174K.
  • Curian Capital first reported a position in Standard BioTools in Q3 2014 and held it in 5 quarters.
  • Curian Capital's Standard BioTools position peaked at $913K in Q1 2015.
  • 106 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2015.

Based on Curian Capital's 13F filing for Q4 2015, filed 25 Jan 2016.